Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Integr Med ; 17(2): 115-124, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30738772

RESUMEN

OBJECTIVE: This study aims to evaluate the vasodilatory effect of Chenopodium ambrosioides on the isolated rat aorta, and to explore its mechanism of action. METHODS: The vasorelaxant effect and the mode of action of various extracts from the leaves of C. ambrosioides were evaluated on thoracic aortic rings isolated from Wistar rats. In addition, ethyl acetate and methanol fractions were analyzed, using thin-layer chromatography and high-performance liquid chromatography techniques, for their polyphenolic content. RESULTS: The various active extracts of C. ambrosioides at four concentrations (10-3, 10-2, 10-1 and 1 mg/mL) relaxed the contraction elicited by phenylephrine, in a concentration-dependent manner. This effect seems to be endothelium-dependent, since the vasodilatory effect was entirely absent in denuded aortic rings. The vasorelaxant effect of the methanol fraction (MF) of C. ambrosioides at 1 mg/mL was also inhibited by atropine and tetraethylammonium. This effect remained unchanged by Nω-nitro-l-arginine methyl ester hydrochloride and glibenclamide. The preliminary phytochemical analysis showed that the leaves of C. ambrosioides are rich in phenolic and flavonoid derivatives. CONCLUSION: These results suggest that the MF of C. ambrosioides produces an endothelium-dependent relaxation of the isolated rat aorta, which is thought to be mediated mainly through stimulation of the muscarinic receptors, and probably involving the opening of Ca2+-activated potassium channels.


Asunto(s)
Aorta Torácica/efectos de los fármacos , Chenopodium ambrosioides/química , Extractos Vegetales/farmacología , Vasodilatadores/farmacología , Animales , Aorta Torácica/fisiología , Endotelio/efectos de los fármacos , Endotelio/fisiología , Técnicas In Vitro , Masculino , Hojas de la Planta/química , Ratas , Ratas Wistar , Vasodilatación/efectos de los fármacos
2.
J Complement Integr Med ; 102013 Jul 06.
Artículo en Inglés | MEDLINE | ID: mdl-23836726

RESUMEN

BACKGROUND: The goal of this study was to examine the effect of Virgin Argan Oil (VAO) obtained from the fruit of Argania spinosa in a model of type 2 diabetes and hypertensive rats. Neonatal diabetes was induced by a single i.p. injection of streptozotocin (90 mg/kg) 2 days after birth. To induce NO-deficient hypertension, the adult diabetic animals were treated with l-nitroarginine methylester (l-NAME) (30 mg/kg/day) given orally for 21 days. METHODS: Following treatment with VAO (21 days), the hyperglycemia decreased to 1.3 ± 0.07 g/l compared with 1.92 ± 0.09 g/l (p < 0.01) in the untreated diabetic-hypertensive rats. The simultaneous administration of VAO with l-NAME prevented the increase in blood pressure during the 3 weeks of treatment. Blood pressure remained constant at 131 ± 1 mm Hg after 21 days - vs 157 ± 0.64 mm Hg in untreated animals (p < 0.001). RESULTS: The treatment with VAO to diabetic-hypertensive rats caused a significant increase of hepatic glycogen levels (13.3 ± 1.8 vs 6.34 ± 0.75 mg/g tissue in untreated diabetic-hypertensive control group; p < 0.01). CONCLUSIONS: In conclusion, the overall findings indicate that VAO possesses antidiabetic and antihypertensive activity in n-stz/l-NAME rats. This effect may be related to its high content of tocopherols, phenolic compounds, and unsaturated fatty acids.


Asunto(s)
Antihipertensivos/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipertensión/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Fitoterapia , Aceites de Plantas/uso terapéutico , Sapotaceae/química , Animales , Animales Recién Nacidos , Antihipertensivos/farmacología , Glucemia/metabolismo , Presión Sanguínea/efectos de los fármacos , Diabetes Mellitus Experimental/metabolismo , Glucógeno/metabolismo , Hiperglucemia/tratamiento farmacológico , Hipertensión/inducido químicamente , Hipertensión/metabolismo , Hipoglucemiantes/farmacología , Hígado/efectos de los fármacos , Hígado/metabolismo , NG-Nitroarginina Metil Éster , Aceites de Plantas/farmacología , Ratas , Ratas Wistar
3.
J Diabetes ; 4(3): 307-13, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22519949

RESUMEN

BACKGROUND: The present study examined the effect of the polyphenol-rich fraction from Thymelaea hirsuta (PRF-Th) in a rat model of streptozotocin (STZ)-diabetes and nitric oxide (NO)-deficient hypertension. METHODS: Diabetes was induced by a single dose of STZ (90 mg/kg, i.p.). To induce NO-deficient hypertension, rats were treated with the NO synthase inhibitor N(G) -nitro-l-arginine methyl ester; l-NAME; 30 mg/kg per day, p.o. for 3 weeks. The effects of 21 days treatment with 80 mg/kg per day PRF-Th in the drinking water were evaluated in diabetic-hypertensive (DH) rats. In all groups (n = 6 in each), glycemia and systolic blood pressure were determined weekly. At the end of the experiment, hepatic glycogen was determined. RESULTS: Blood glucose levels decreased gradually from baseline until the end of the experiment in untreated DH rats (from 1.92 ± 0.09 to 1.3 ± 0.1 g/L; P < 0.05). Administration of PRF-Th concomitantly with l-NAME prevented the blood pressure increase in rats. After 21 days, blood pressure in PRF-Th + l-NAME- and l-NAME-treated rats was 132 ± 1 and 157 ± 1 mmHg, respectively (P < 0.001). Administration of 2 mL/kg per day PRF-Th to DH rats significantly increased hepatic glycogen levels compared with levels in untreated DH rats (13.65 ± 1.84 vs 6.34 ± 0.75 mg/g tissue, respectively; P < 0.01). Moreover, PRF-Th significantly reduced the amount of glucose absorbed in in situ perfused jejunum segments compared with control (by 33.6%; P <0.001). This effect of PRF-Th was comparable with that of acarbose, an α-glucosidase inhibitor. CONCLUSIONS: The findings of the present study indicate that T. hirsuta has antidiabetic and antihypertensive activity in STZ-diabetic, NO-deficient hypertensive rats. This effect seems to be due to its rich polyphenol content. Therefore, T. hirsuta may be useful as a food supplement for the prevention of type 2 diabetes and hypertension.


Asunto(s)
Antihipertensivos/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipertensión/tratamiento farmacológico , Hipoglucemiantes/farmacología , Polifenoles/farmacología , Thymelaeaceae/química , Animales , Animales Recién Nacidos , Glucemia/metabolismo , Presión Sanguínea/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/inducido químicamente , Femenino , Glucosa/metabolismo , Glucosa/farmacocinética , Hipertensión/sangre , Hipertensión/inducido químicamente , Yeyuno/efectos de los fármacos , Yeyuno/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Glucógeno Hepático/metabolismo , Masculino , NG-Nitroarginina Metil Éster , Fitoterapia , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Estreptozocina , Factores de Tiempo , Resultado del Tratamiento
4.
Phytother Res ; 26(2): 180-5, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21584872

RESUMEN

The argan tree plays an important socioeconomic and ecologic role in South Morocco. Moreover, there is much evidence for the beneficial effects of virgin argan oil (VAO) on human health. Thus, this study investigated whether administering VAO to rats can prevent the development of diabetes. VAO extracted by a traditional method from the almonds of Argania spinosa (2 mL/kg) was administered orally (for 7 consecutive days) to rats before and during intraperitoneal alloxan administration (75 mg/kg for 5 consecutive days). An alloxan diabetic-induced untreated group and treated by table oil were used as control groups. Body mass, blood glucose and hepatic glycogen were evaluated. In the present study, subchronic treatment with VAO at a dose of 2 mL/kg, before the experimental induction of diabetes, prevented the body mass loss, induced a significant reduction of blood glucose and a significant increase of hepatic glycogen level (p < 0.001) compared with the untreated diabetic group. In conclusion, the present study shows that argan oil should be further investigated in a human study to clarify its possible role in reducing weight loss in diabetics, and even in inhibiting the development or progression of diabetes. This antidiabetic effect could be due to the richness of VAO in tocopherols, phenolic compounds and unsaturated fatty acids.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Aceites de Plantas/farmacología , Aloxano , Animales , Glucemia/análisis , Peso Corporal , Diabetes Mellitus Experimental/inducido químicamente , Glucógeno/análisis , Hipoglucemiantes/uso terapéutico , Aceites de Plantas/uso terapéutico , Ratas , Ratas Wistar , Sapotaceae/química
5.
Curr Diabetes Rev ; 6(4): 247-54, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20522017

RESUMEN

The aim of this study is to collate all available data on antidiabetic plants that inhibit alpha glucosidase, reported mainly by Medline (PubMed) these last years. In the present study, interest is focused on experimental researches conducted on hypoglycemic plants particularly those which show alpha glucosidase inhibitor activity alongside bioactive components. This study describes 47 species that belong to 29 families. The plant families, which enclose the species, studied most as inhibitors of alphaglucosidase, are Fabaceae (6 species.), Crassulaceae (3 species), Hippocrateacaea (3 species), Lamiaceae (3 species), and Myrtaceae (3 species), with most studied species being Salacia reticulata (Hippocrateaceae) and Morus alba (Moraceae). The study also covers natural products (active natural components and crude extracts) isolated from the medicinal plants which inhibit alpha glucosidase as reported this last decade. Many kinds of these isolated natural products show strong activity such as, Alkaloids, stilbenoids (polyphenol), triterpene, acids (chlorogenic acid, betulinic acid, syringic acid, vanillic acid, bartogenic acid, oleanolic acid, dehydrotrametenolic acid, corosolic acid, ellagic acid, ursolic acid, gallic acid), phytosterol, myoinositol, flavonoids, Flavonolignans, anthraquinones, anthrones, and xanthones, Feruloylglucosides, flavanone glucosides, acetophenone glucosides, glucopyranoside derivatives, genine derivatives, flavonol, anthocyanin and others.


Asunto(s)
Diabetes Mellitus/tratamiento farmacológico , Inhibidores Enzimáticos/uso terapéutico , Inhibidores de Glicósido Hidrolasas , Hipoglucemiantes/uso terapéutico , Plantas Medicinales , Animales , Inhibidores Enzimáticos/aislamiento & purificación , Inhibidores Enzimáticos/farmacología , Humanos , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/farmacología , Fitoterapia , Extractos Vegetales/uso terapéutico , Plantas Medicinales/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...